Evidence map›Paper›PMID 24073050›Full record

ArticleTranslational behavioral medicine2011

The China Seven Cities Study (CSCS) consortium: adapting evidence-based prevention science from west to east.

Paula H Palmer, Bin Xie, Liming Lee, Chih-Ping Chou, Ping Sun, Bree Hemingway, C Anderson Johnson

Abstract read
In one paragraph

Article in Translational behavioral medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paula H PalmerSchool of Community & Global Health, Claremont Graduate University, 180 East Via Verde, Suite 100, San Dimas, CA 91773 USA.
Bin Xie
Liming Lee
Chih-Ping Chou
Ping Sun
Bree Hemingway
C Anderson Johnson

Funding

TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERP50CA084735 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AZEN, STANLEY P · 1999 to 2008
$18.0M
NCI NIH HHS P50 CA084735
6 · The paper itself

Abstract

Chronic, noncommunicable diseases (NCDs) have surpassed infectious diseases as the primary cause of death and disability in most developing nations. Nowhere is this more evident than in China where NCDs account for 80% of all deaths and skyrocketing medical costs. Driving the escalation of NCDs are high rates of tobacco use, longer life spans, and changes in the traditional Chinese diet and lifestyle bolstered by unprecedented economic growth and the new global culture. Despite the epidemic of NCDs, few evidence-based interventions either to prevent or retard their progression exist in China. We present a case for the development and adoption of such strategies as effective tools to combat China's greatest health threat. Finally, we offer an example of a collaborative network linking Chinese public health and academic institutions with US researchers to promote the translation of western evidence-based interventions that fully incorporate local knowledge, culture, and capacity.

Indexed as

ChinaEvidence-basedNoncommunicable diseaseTobacco control

Identifiers

PMID24073050
PMCPMC3717648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.